Showing results (1-10 of 346) with videos related to
Sort By:
Pageof 35
Journal of Immunotoxicology|October 30, 2008
Erythropoietin-Associated PRCA: Still an Unsolved MysteryHuub Schellekens, Wim JiskootPharmaceutical Research|July 12, 2011
Immunogenicity of therapeutic proteins: the use of animal modelsVera Brinks, Wim Jiskoot, Huub SchellekensTrends in Pharmacological Sciences|December 8, 2009
Immunological mechanism underlying the immune response to recombinant human protein therapeuticsMelody Sauerborn, Vera Brinks, Wim Jiskoot, et al.Pharmaceutical Research|January 31, 2013
Effect of treatment regimen on the immunogenicity of human interferon Beta in immune tolerant miceGrzegorz Kijanka, Wim Jiskoot, Huub Schellekens, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 30, 2010
On the role of aggregates in the immunogenicity of recombinant human interferon beta in patients with multiple sclerosisMiranda M C van Beers, Wim Jiskoot, Huub SchellekensPharmaceutical Research|January 17, 2004
Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?Suzanne Hermeling, Huub Schellekens, Daan J A Crommelin, et al.Pharmaceutical Research|June 11, 2005
Development of a transgenic mouse model immune tolerant for human interferon BetaSuzanne Hermeling, Wim Jiskoot, Daan Crommelin, et al.Pharmaceutical Research|June 24, 2004
Structure-immunogenicity relationships of therapeutic proteinsSuzanne Hermeling, Daan J A Crommelin, Huub Schellekens, et al.Pharmaceutical Research|March 10, 2006
Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactionsSuzanne Hermeling, Wim Jiskoot, Daan J A Crommelin, et al.Pharmaceutical Research|February 28, 2009
Immunological risk of injectable drug delivery systemsWim Jiskoot, Rianne M F van Schie, Myrra G Carstens, et al.Pageof 35